{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:56:04Z","timestamp":1789606564826,"version":"build-2803163510"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study determined whether alkaline phosphatase (ALP) can be used to distinguish giant cell arteritis (GCA) complications in patients with polymyalgia rheumatica (PMR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study included patients diagnosed with PMR between January 2014 and October 2023 at our hospital. The predictive accuracy of biomarkers for diagnosing GCA was evaluated. Logistic regression was performed to identify factors predicting GCA complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 128 participants were included in this study and divided into two groups: isolated PMR (n\u2009=\u2009111) and PMR with GCA (n\u2009=\u200917). The median ALP level of PMR with GCA group was significantly higher than that of the isolated PMR group (242.0 [interquartile range, 221.0\u2013595.0] vs. 187.0 [interquartile range 97.5\u2013254.5] U\/L, P\u2009&amp;lt;\u2009.001). Setting a cut-off value of 214\u2009U\/L for ALP yielded a sensitivity and specificity of 0.88 and 0.55, respectively, for diagnosing GCA. Multivariate analysis revealed that ALP was a significant independent variable in the complications of GCA (odds ratio, 25.2; P\u2009=\u2009.032).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ALP can help distinguish GCA complications in patients with PMR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/roae101","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:59:39Z","timestamp":1731574779000},"page":"529-534","source":"Crossref","is-referenced-by-count":2,"title":["Alkaline phosphatase is useful for predicting giant cell arteritis complications in patients with polymyalgia rheumatica"],"prefix":"10.1093","volume":"35","author":[{"given":"Ryo","family":"Yamashita","sequence":"first","affiliation":[{"name":"Department of General Medicine, The Jikei University School of Medicine, Daisan Hospital , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The Jikei University School of Medicine, Daisan Hospital , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hiramoto","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The Jikei University School of Medicine, Daisan Hospital , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"2025050812122378400_R1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Frank","year":"2016","journal-title":"JAMA"},{"key":"2025050812122378400_R2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025050812122378400_R3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2025050812122378400_R4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Gerald","year":"2002","journal-title":"JAMA"},{"key":"2025050812122378400_R5","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/annrheumdis-2013-203322","article-title":"Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)","volume":"73","author":"Ana","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025050812122378400_R6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Carlo","year":"2008","journal-title":"Lancet"},{"key":"2025050812122378400_R7","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Miguel","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025050812122378400_R8","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Christian","year":"2017","journal-title":"Rheumatology"},{"key":"2025050812122378400_R9","article-title":"Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica \u2013 a systematic review and meta-analysis","volume":"56","author":"Andreas","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025050812122378400_R10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/14397595.2015.1071304","article-title":"MMP-3 can distinguish isolated PMR from PMR with GCA: a retrospective study regarding PMR and GCA in Japan","volume":"26","author":"Fukui","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2025050812122378400_R11","article-title":"Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica \u2013 a prospective cohort study","volume":"15","author":"Lara","year":"2023","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025050812122378400_R12","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica a systematic review and meta-analysis of individual patient data","volume":"55","author":"Andrea","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025050812122378400_R13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica","volume":"63","author":"Eugenio","year":"2024","journal-title":"Rheumatology"},{"key":"2025050812122378400_R14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(97)00117-4","article-title":"Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica","volume":"102","author":"Valverde","year":"1997","journal-title":"Am J Med"},{"key":"2025050812122378400_R15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0950-3579(05)80066-4","article-title":"Laboratory investigations including liver in polymyalgia rheumatica\/giant cell arteritis","volume":"5","author":"Valerie","year":"1991","journal-title":"Baillieres Clin Rheumatol"},{"key":"2025050812122378400_R16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Bhaskar","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025050812122378400_R17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/art.42325","article-title":"American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"74","author":"Cristina","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025050812122378400_R18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/rheumatology\/kex143","article-title":"Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis","volume":"56","author":"Sch\u00e4fer","year":"2017","journal-title":"Rheumatology"},{"key":"2025050812122378400_R19","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1007\/s00330-018-5311-8","article-title":"CT analysis of the aorta in giant-cell arteritis: a case-control study","volume":"28","author":"Pierre","year":"2018","journal-title":"Eur Radiol"},{"key":"2025050812122378400_R20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/ard.40.1.92","article-title":"Hepatocellular disease in the giant-cell arteritis\/polymyalgia rheumatica syndrome","volume":"40","author":"Leong","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"2025050812122378400_R21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jcp.34.7.769","article-title":"Hepatic artery involvement in polymyalgia arteritica","volume":"34","author":"Ogilvie","year":"1981","journal-title":"J Clin Pathol"},{"key":"2025050812122378400_R22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF02208693","article-title":"Liver scan abnormalities in polymyalgia rheumatica\/giant cell arteritis","volume":"10","author":"Kyle","year":"1991","journal-title":"Clin Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roae101\/60964834\/roae101.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/35\/3\/529\/60964834\/roae101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/35\/3\/529\/60964834\/roae101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T16:12:32Z","timestamp":1746720752000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/35\/3\/529\/7900086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,11,14]]},"published-print":{"date-parts":[[2025,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roae101","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,11,14]]}}}